Search

Begin New Search Topic Science and Technology Publication Year within 25 Years

1881. Nuclear Energy Today

Publication Date:
02-2005
Content Type:
Policy Brief
Institution:
The Organisation for Economic Co-operation and Development
Abstract:
Nuclear energy has been used to produce electricity for more than half a century. It currently provides about 17% of the world's supply and 23% in OECD countries. The oil crisis of the early 1970s provoked a surge in nuclear power plant orders and construction, but as oil prices stabilised and even dropped, and enough electricity generating plants came into service to meet demand, orders tailed off. Accidents at Three Mile Island in the United States (1979) and at Chernobyl in Ukraine (1986) also raised serious questions in the public mind about nuclear safety.
Topic:
International Relations, Development, Nuclear Weapons, and Science and Technology
Political Geography:
United States and Ukraine

1882. Climate Change Science: Time for "Team B"?

Author:
Steven F. Hayward
Publication Date:
02-2005
Content Type:
Policy Brief
Institution:
American Enterprise Institute for Public Policy Research
Abstract:
The Intergovernmental Panel on Climate Change (IPCC) is currently working on its fourth assessment report. Despite the IPCC's noble intent to generate a scientific consensus, a number of factors have compromised the research and drafting process, assuring that its next assessment report will be just as controversial as previous reports in 1995 and 2001. Efforts to reform this large bureaucratic effort are unlikely to succeed. Perhaps the time has come to consider competition as the means of checking the IPCC's monopoly and generating more reliable climate science.
Topic:
Environment, Government, and Science and Technology
Political Geography:
United States

1883. Junk Science Reigns

Author:
John E. Calfee
Publication Date:
09-2005
Content Type:
Policy Brief
Institution:
American Enterprise Institute for Public Policy Research
Abstract:
If we know anything about the American tort liability system, we know that it works badly when it gets infected by junk science. The recent Vioxx verdict in Angleton, Texas, is a case in point. The jury awarded $253 million to the widow of a man who died after taking the now-infamous pain reliever. The award will almost certainly be reduced to something like $5 million or $10 million because it ignored statutory limits on punitive damages, and it may eventually get thrown out because of mistakes by the judge. But even at “only” $10 million a case, a string of adverse Vioxx decisions would prove an expensive example of the triumph of the junk lawsuit over science. Most press accounts portray the jury's decision as simply a reflection of medical science, which supposedly has indicted and convicted Vioxx of causing excess heart attacks. This view prevailed in the four months after September 30, 2004, when Merck voluntarily pulled Vioxx from the market. Those months saw vituperous debate and criticism of both Merck and the Food and Drug Administration in leading medical journals. A renegade FDA staffer testified at congressional hearings along with other critics.
Topic:
Development, Government, Human Welfare, and Science and Technology
Political Geography:
America

1884. Small Leaps or Giant Leaps

Author:
Scott Gottlieb
Publication Date:
07-2005
Content Type:
Policy Brief
Institution:
American Enterprise Institute for Public Policy Research
Abstract:
There are seldom eureka moments in health care. Few new drugs or medical devices save scores of lives or cure diseases when they first hit the market. New technologies rarely translate into immediate life expectancy gains, and it is uncommon that results of a single study will transform how medicine is practiced. Medical progress is not magic, and sudden discoveries do not lead to dramatic cures, although a new book by Marcia Angell, a former editor of The New England Journal of Medicine, would lead you to think all of our gains in health have been achieved from just a handful of the most potent new medicines. Instead, medical breakthroughs unfold over time, and gains in life expectancy and health are realized only after a series of small technological advances are collected into new ways of practicing medicine or attacking a disease. The practice of medicine unfolds not in a series of certainties, but in a series of doubts.
Topic:
Civil Society, Development, Human Welfare, and Science and Technology
Political Geography:
England

1885. A Case for Government-Sponsored Monitoring of Preimplantation Genetic Diagnosis in the United States

Author:
Aaron D. Levine
Publication Date:
05-2005
Content Type:
Journal Article
Journal:
Journal of Public and International Affairs (JPIA)
Institution:
School of Public and International Affairs (SPIA), Princeton University
Abstract:
Preimplantation genetic diagnosis (PGD), a modified version of in vitro fertilization in which individual embryos are screened for specific genetic characteristics prior to implantation, provides a powerful way for parents suffering from infertility to increase their chances of having healthy children. In its various forms, PGD allows parents to screen for gender, providing a means for avoiding X-linked diseases, chromosomal abnormalities, such as translocations and aneuploidies, and single-gene disorders. Beyond these standard uses, PGD could potentially be used to select for any genetic trait, and this aspect of the technology has raised concerns that it may be used either intentionally or unintentionally for eugenic purposes. At present, reproductive medicine is only loosely regulated in the United States and new technologies, such as PGD, are almost entirely unregulated. This paper argues that given the lack of consensus regarding the ethical acceptability of PGD and embryo selection techniques, the government has an interest in gathering and reporting data on the use of PGD in the United States. Taking a proactive role now, rather than allowing the use of PGD to continue growing unscrutinized, will give society the chance to make thoughtful and deliberate decisions about its use.
Topic:
Government, Science and Technology, Medicine, Reproductive Health, and Genetics
Political Geography:
North America and United States of America

1886. Science for Global Sustainability: Toward a New Paradigm

Author:
William C. Clark, Paul J. Crutzen, and Hans J. Schellnhuber
Publication Date:
03-2005
Content Type:
Working Paper
Institution:
The John F. Kennedy School of Government at Harvard University
Abstract:
This paper provides a context for the Dahlem Workshop on “Earth System Analysis for Sustainability.” The authors begin by characterizing the contemporary epoch of Earth history in which humanity has emerged as a major—and uniquely self-reflexive—geological force. They turn next to the extraordinary revolution in our understanding of the Earth system that is now underway, pointing out how it has built on and qualitatively extended the approaches that have served science and society so well since the first Copernican revolution. The authors then discuss the novel challenges posed by the urgent need to harness science and other forms of knowledge in promoting a worldwide sustainability transition that enhances human prosperity while protecting the Earth’s life-support systems and reducing hunger and poverty. Finally, the authors provide an overview of how the contributions to this Dahlem Workshop addressed the themes and challenges outlined in this introductory chapter.
Topic:
Development, Environment, Science and Technology, Institutions, Sustainability, Resilience, and Integrated Systems
Political Geography:
Global Focus

1887. Demand Policy Instruments for R Procurement, Technical Standards and The Case of Indian Vaccines

Author:
Smita Srinivas
Publication Date:
12-2004
Content Type:
Working Paper
Institution:
Belfer Center for Science and International Affairs, Harvard University
Abstract:
Vaccines represent a nearly $8 billion global industry today , which is projected to grow to $10 billion in 2010 (PhRMA, 2001). In 2001, worldwide spending on R for “biologicals,” of which vaccines are the largest segment, was $1.1 billion (about 4% of total private pharmaceutical R) (PhRMA, 2001). Although vaccines com p rise only 2% of the global pharmaceutical market, it is indispensable for public health immunization the world over. Yet, at the same time, the number of private vaccine suppliers in advanced industrialised countries is shrinking (in the US alone, there were over twenty vaccine suppliers until the 1970s and now approximately five exist); firm s in developing countries must pick up some of this slack, especially for vaccines that are especially important for diseases prevalent in developing countries.
Topic:
Energy Policy, Human Welfare, Industrial Policy, and Science and Technology

1888. Drug Reimportation: The Free Market Solution

Author:
Roger Pilon
Publication Date:
08-2004
Content Type:
Working Paper
Institution:
The Cato Institute
Abstract:
As modern "miracle drugs" play a growing role in medical practice, drug prices in America soar far beyond prices in the rest of the world. Yet our law prohibits Americans from buying American-made drugs abroad at those prices and "reimporting" them to the United States. That has led many Americans, and even some state and local officials, to ignore the law and go to Canada and Mexico for their drugs; to the passage in the House last year of a bill lifting the ban on reimportation; and to similar bills now in the Senate—legislation that Health and Human Services Secretary Tommy Thompson recently called "inevitable."
Topic:
Human Welfare, International Trade and Finance, and Science and Technology
Political Geography:
United States, America, Canada, and Mexico

1889. WTO, E-commerce, and Information Technologies: From the Uruguay Round through the Doha Development Agenda

Author:
Sacha Wunsch-Vincent
Publication Date:
11-2004
Content Type:
Working Paper
Institution:
Peterson Institute for International Economics (PIIE)
Abstract:
Although much of the early Internet hype has faded, e-commerce continues to grow and spread around the world. In recent years, the potential and importance of e-commerce to the economies and industries of the developing world has become particularly evident. Yet as e-commerce develops into a global phenomenon, the need for rules and principles facilitating e-commerce has become increasingly evident, too.
Topic:
Development, Economics, International Trade and Finance, and Science and Technology
Political Geography:
Uruguay

1890. The World's Nuclear Arsenals

Author:
Ali Chaudhry and Andrew George
Publication Date:
07-2004
Content Type:
Working Paper
Institution:
Center for Defense Information
Abstract:
Though the exact size of China's nuclear arsenal is unknown, current best estimates are that China has about 280 strategic weapons, and a smaller number — about 120 — of tactical weapons. The weapons are based on intercontinental ballistic missiles (ICBMs) and strategic bombers, with a naval component under research.
Topic:
Security, Arms Control and Proliferation, Nuclear Weapons, and Science and Technology
Political Geography:
China